Anti-CD47 Agent Boosts Macrophage Activity in NHL.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2018-155
Abstract: The anti-CD47 drug Hu5F9-G4, also known as 5F9, in combination with the anti-CD20 therapy rituximab, may be a promising treatment for some forms of non-Hodgkin lymphoma because it allows macrophages to recognize and attack cancer… read more here.
Keywords: agent boosts; macrophage activity; activity nhl; anti cd47 ... See more keywords